Encyclopedia of AIDS

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Hope, Thomas J. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Richman, Douglas (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Stevenson, Mario (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: New York, NY : Springer New York : Imprint: Springer, 2018.
• Έκδοση: 1st ed. 2018.
• Θέματα: Infectious diseases.; Immunology.; Virology.; Infectious Diseases.

For the first time, the world's experts in HIV-AIDS have come together to publish the Encyclopedia of AIDS. The work features over 4,000 A-Z entries including medical, cultural, social, and pharmacological essays. The Pathology entries cover the various types of HIV-related illnesses, including...

Πίνακας περιεχομένων:

• Abstinence, Be Faithful, Condoms (ABC), Prevention of HIV
• Acetylation
• Actin
• AIDS-related
• Primary Central Nervous System Lymphoma
• Anal Cancer
• Anatomic Compartments as a Barrier to HIV Cure
• Antiretroviral Drug Penetration into Lymphoid Tissue
• Antiretroviral Drug Penetration into the CNS Compartment
• Antiretroviral Medications, Adult Care and Treatment
• Antiretroviral therapy (ART), Prevention of HIV
• Anti-Retroviral Therapy and Drug Resistance in HIV-2 Infection
• Antiretroviral Therapy for HIV-Infected Infants, Children, and Adolescents in Resource-Rich Settings
• Antiretroviral Therapy: When to Start
• Antiretroviral Treatment in Resource-Limited Settings
• APOBEC3F/G and Vif: Action and Counteractions
• Apoptosis Dysregulation during HIV Disease.-Arp2/3
• Attachment/Binding
• Autophagy and HIV Infection
• Bacterial Respiratory and Invasive Pneumococcal Infections and HIV
• BAF (BANF1)
• Behavioral Aspects of HIV Mother-to-Child Transmission
• Behavioral Aspects of HIV Treatment as Prevention
• Behavioral Interventions for Adherence
• Behavioral Science highlights of evidence and research
• Blood and blood product donors and recipients in China, Epidemiology of HIV/AIDS
• Budding
• Burkitt and Burkitt-like Lymphoma
• Cardiovascular Complications
• cART and Supportive Care for HIV-Associated Malignancies
• Case Management for Linkage
• Cell Intrinsic Immunity
• Cellular and Soluble Immune Activation Markers in HIV-Infected Subjects
• Cellular Cofactors for HIV-1 Transcription
• Cellular Cofactors of HIV as Drug Targets
• Central Memory CD4 T cells
• Cervical Cancer and HIV
• Chagas Disease and HIV
• Children, Care and Treatment
• Children, Epidemiology of HIV/AIDS
• Chronic Immune Activation in HIV
• Circumcision and AIDS
• Clinical Ethics in HIV/AIDS Prevention, Care, and Research
• Cofilin, Trafficking
• Collagen Deposition and Fibrosis in the Lymphatic Tissues of HIV-1 Infected Individuals
• Combination Approaches to HIV Prevention
• Community Viral Load
• Co-morbidity: Opiods
• Comorbidity: Progressive Multifocal Leukoencephalopathy
• Conjunctival Carcinoma
• Counteraction of SAMHD1 by Vpx
• Chromosome Region Maintenance 1 (CRM1)
• Cryptococcosis and HIV
• Cryptosporidiosis
• Epidemic Kaposi Sarcoma, Pathogenesis and Presentation of
• CXCR4, Coreceptors
• Cyclophilin A and HIV-1 Replication
• Cystoisosporiasis
• Cytomegalovirus Infection and HIV
• DDX3, Cofactors, and RNA Export
• Delayed Sexual Debut
• Dendritic Cell Interactions with HIV-1 Envelope Glycoprotein, Implications for Preventing Transmission
• Differential Diagnosis of HIV-Associated Neurocognitive Disorders
• Diffuse Large B-Cell Lymphoma
• Eastern Europe and Central Asia, specific characteristics of HIV/AIDS epidemic
• Elderly: Epidemiology of HIV/AIDS
• Entry Inhibitors
• Epidemiology of AIDS-Defining Malignancies
• Epidemiology of HIV-2 Infection in West Africa
• Epidemiology of Non-AIDS-Defining Malignancies
• Epstein Barr Virus (EBV)
• Faith Based Interventions
• Family Interventions
• Female Condoms
• Female, Male and Transgender Sex Workers, Epidemiology of HIV/AIDS
• Fusion
• Gamma delta T cells
• Global NeuroAIDS
• HAND Adjunctive Therapies: Reversing Neuronal Injury
• Harm Reduction for Injection Drug Users
• Health care workers, Epidemiology of HIV/AIDS
• Health care workers, Shortage and task shifting of
• Hepatitis B Virus infection and HIV
• Hepatitis C Virus Infection and HIV
• Hepatocellular Carcinoma in HIV-Positive Patients
• History of the AIDS epidemic
• HIV "auxiliary" proteins, essential role of
• HIV & SIV, CD4 T cell responses to
• HIV and Opportunistic Infections, an Overview
• HIV and Sexual Violence
• HIV and SIV, B-Cell Responses to
• HIV and SIV, CD8 T Cell Responses to
• HIV Antigen Processing and Presentation
• HIV Associated Immune Exhaustion
• HIV Cancers in Resource-Limited Regions
• HIV Compartments and Viral Rebound During Treatment Interruption
• HIV Coreceptor Tropism in Different Reservoirs
• HIV Counseling and Testing, Prevention of HIV
• HIV Funding agencies and major programs
• HIV Infection, Immune-based Interventions for
• HIV Life Cycle: Overview
• HIV Neurocognitive Diagnosis, Natural History and Treatment
• HIV Prevention and African Americans
• HIV Prevention and Asians and Pacific Islanders
• HIV Prevention and Hispanics
• HIV Prevention and Labor Migration
• HIV Prevention and Women
• HIV Prevention Efforts Within Substance Use Disorder Treatment Settings
• HIV Prevention for MSM
• HIV Prevention for Serodiscordant Couples
• HIV Prevention for Stimulant Using Men Who have Sex with Men
• HIV Prevention in Persons 50 and Older
• HIV Prevention in the Correctional System
• HIV Prevention in Transgender Persons
• HIV Prevention in Youth
• HIV Reservoirs in Lymph Nodes and Spleen
• HIV Reservoirs in the Central Nervous System
• HIV Reservoirs Within the Lungs
• HIV Testing and Counseling
• HIV Transmission in Female Commercial Sex Workers and Host Protective Factors
• HIV-1 Assembly Cofactors
• HIV-1 Maturation
• HIV-1 Mutational Escape from Host Immunity
• HIV-1 Pathogenesis in the Gut
• HIV-1 Pre-Exposure Prophylaxis
• HIV-1 Prevention Using Live-attenuated Vaccines
• HIV-1 Rev Expression and Functions
• HIV-1 Transmission Blocking Microbicides
• HIV-1 Transmission; Influence of Bodily Secretions
• HIV-1 Virion Structure
• HIV-2 Diagnosis and Viral Load Measurements
• HIV-2 Envelope: Structure, Diversity and Evolution
• HIV-2 Infection in Europe, Epidemiology of
• HIV-2 Infection: The Role of Immune Activation in Pathogenesis
• HIV-2 Neurological Manifestations
• HIV-2 Transmission
• HIV-2: Lessons from the Dakar Cohort
• HIV-Associated Cancers
• Hodgkin Lymphoma in Patients with HIV Infection
• Host Genetics and Genomics
• Housing as HIV Prevention
• Human Papillomavirus (HPV)
• Identification and Validation of HIV Cofactors
• Identifying Opportunities to Block HIV-1 Transmission in the Female Genital Tract
• Immune Activation and HIV Transmission
• Immunogenetics of HIV-2 Infection
• Immunological Responses to Antiretroviral Therapy
• Immunology of Latent HIV Infection
• Immunopathogenesis of HIV Co-infections
• Inflammasome and HIV
• Inflammatory Cytokines
• Inhibition of HIV-1 Spread: Cell-Free Versus Cell-Cell
• Initial Antiretroviral Regimens
• Integrase Inhibitors
• Integration
• Integrin Alpha4beta7
• Interactions Between HIV-2 and Host Restriction Factors
• Kaposi's Sarcoma-associated Herpesvirus (KSHV) or Human Herpesvirus 8 (HHV-8)
• KIR Locus Variation
• Latin America and the Caribbean, specific characteristics of HIV/AIDS epidemic
• Leishmaniasis and HIV
• Long-Acting Nanoformulated Antiretroviral Therapy
• Long-Term Nonprogressors and Elite Controllers
• Lung Cancer
• M.
• avium Complex and Other Nontuberculous Mycobacteria and HIV
• Macrophages in HIV Immunopathogenesis
• Macrophage-Specific Aspects of HIV-1 Infection
• Male Condoms
• Malignancies in Children with HIV Infection
• Management of AIDS-related Kaposi's Sarcoma
• Mass Media and HIV Prevention
• Maturation Inhibitor
• Medical male circumcision, infant circumcision, Prevention of HIV
• Men who have sex with men (MSM), Epidemiology of HIV/AIDS
• Merkel Cell Carcinoma and Other HIV-Associated Skin Cancers
• Merkel Cell Polyomavirus (MCV)
• MHC Locus Variation
• Microbial Translocation
• Microfinance/Microenterprise Approaches to HIV Prevention
• Microsporidiosis
• Molecular Biology of HIV-2
• Mother-to-Child Transmission of HIV-1: Role of Receptor Usage and Target Cells
• MTCT HIV-1 Transmission Update: Transmission Routes & Mechanisms
• Mucosal Immunity to HIV-1
• Mucosal Pathogenesis in SIV Infection
• Multicentric Castleman Disease
• Multilevel Interventions/Structural Approaches to HIV Prevention
• MX2 and HIV-1 Restriction
• Natural History and Clinical Features of HIV-2 Infection
• Natural Killer Cells and Innate Immunity in HIV-2 Infection
• Natural Killer Cells and their Role in Preventing HIV-1 Transmission
• Nef/Env/Vpu/Tetherin
• Network Interventions
• NeuroAIDS in Resource-Poor Settings, Assessment, and Treatment of
• Neuro-AIDS, Immunopathogenesis of
• Neurocognitive Functioning in HIV Substance Users
• Neurocognitive Outcomes in HIV-Infected Children and Adolescents
• Neuroinflammation and HAND: Therapeutic Targeting
• Neuropsychological testing in HIV infected individuals
• Neurotoxic Consequences of Antiretroviral Therapies
• NKT Cells: Bridging Innate and Adaptive Immunity
• Nonhuman Primate Models of HIV Transmission
• Non-injecting drug users, Epidemiology of HIV/AIDS
• Non-Neutralizing Antibody Responses and Protection Against HIV-1
• Non-Nucleoside Reverse Transcriptase Inhibitors for Treatment of HIV Infection
• Non-Pathogenic SIV Infection of Sooty Mangabeys
• Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTIs)
• Nuclear Import: HIV-1 Goes NUPs
• Nurse-Delivered Interventions for Adherence
• Origin and Distribution of HIV-1 Subtypes
• Other HPV-Associated Cancers (Oropharyngeal and Penile)
• Overcoming the Transcriptional Block: The HIV-1 Tat Auxiliary Protein
• Overview of HIV CNS Infection
• Overview: Immunopathogenesis
• Programmed Death-1
• Peer-Based Intervention Approaches
• Phylogeographic Insights into the Origins and Epidemic History of the Human Immunodeficiency Virus Type 2
• PIMT/TGS1
• PKR and HIV Replication
• Plasmablastic Lymphoma
• Pneumocystis Jirovecii Infection and HIV
• Positive Health, Dignity, and Prevention (PHDP)
• Post-treatment Controllers
• Preexposure Prophylaxis (PrEP)
• Pregnant Women: Care and Treatment
• Presentation and Pathogenesis of B-Cell Lymphoid Cancers Associated with HIV Infection
• Preventing HIV-1 Transmission Through Vaccine-Induced Immune Responses
• Preventing Mother-to-Child Transmissi.